Table I.
Six DELs that are co-expressed with the ABAT gene.
| DELs | Name | Location | Strand | Regulation type | PCC | P-value |
|---|---|---|---|---|---|---|
| lncRNA1 | None | chr4:13067152-13347902 | Forward | Up | −0.968 | 0.018 |
| lncRNA2 | Jh591181.2/kb663606.1 | chr10:46972944-46982894 | Forward | Up | 0.963 | 0.036 |
| lncRNA3 | Loc100131564/RP4-717I23.3 | chr1:93796837-93806487 | Reverse | Down | 0.979 | 0.021 |
| lncRNA4 | lncENST00000444102 | chr6:167382710-167411729 | Reverse | Down | 0.988 | 0.011 |
| lncRNA5 | Jh806582.2/g1383563.2 | chr17:49425-59050 | Reverse | Down | 0.959 | 0.041 |
| lncRNA6 | None | chr5:61931044-61948469 | Reverse | Up | −0.954 | 0.046 |
Student's t-test was used to identify DELs and DEMs between MDS and non-MDS by calculation of P<0.05 and fold change (FC) >2 for each DEL. Pairs with a PCC threshold >0.95 and P<0.05 were used to construct the ABAT and DEL co-expression association matrix. ABAT, 4-aminobutyrate aminotransferase; MDS, myelodysplastic syndrome; DELs, differentially expressed lncRNAs; DEMs, differentially expressed mRNAs; PCC, Pearson correlation coefficient.